Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01

The outcome of refractory/relapsed (R/R) acute leukemias is still dismal and their treatment represents an unmet clinical need. However, allogeneic transplantation (allo-HSCT) remains the only potentially curative approach in this setting. A prospective study (GANDALF-01, NCT01814488; EUDRACT:2012-0...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonifazi, Francesca, Pavoni, Chiara, Peccatori, Jacopo, Giglio, Fabio, Arpinati, Mario, Busca, Alessandro, Bernasconi, Paolo, Grassi, Anna, Iori, Anna Paola, Patriarca, Francesca, Brunello, Lucia, Di Grazia, Carmen, Carella, Angelo Michele, Cilloni, Daniela, Picardi, Alessandra, Proia, Anna, Santarone, Stella, Sorasio, Roberto, Carluccio, Paola, Chiusolo, Patrizia, Cupri, Alessandra, Luppi, Mario, Nozzoli, Chiara, Baronciani, Donatella, Casini, Marco, Grillo, Giovanni, Musso, Maurizio, Onida, Francesco, Palazzo, Giulia, Parma, Matteo, Tringali, Stefania, Vacca, Adriana, Vallisa, Daniele, Sacchi, Nicoletta, Oldani, Elena, Masciulli, Arianna, Gheorghiu, Angela, Girmenia, Corrado, Martino, Massimo, Bruno, Benedetto, Rambaldi, Alessandro, Ciceri, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200637/
https://www.ncbi.nlm.nih.gov/pubmed/35413985
http://dx.doi.org/10.1038/s41409-022-01626-5

Ejemplares similares

Ejemplares similares